Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T12:45:21.788Z.
Calculation as of: 2026-10-06T12:45:21.788Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Alamar Biosciences, Inc.
Market Cap
$2.64B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.64B
Free Cash Flow Yield
N/A
TTM Avg
3.15%
3Y Avg
3.15%
5Y Avg
3.15%
Market Cap
$2.69B
Free Cash Flow Yield
N/A
TTM Avg
0.77%
3Y Avg
2.82%
5Y Avg
3.32%
Market Cap
$2.69B
Free Cash Flow Yield
5.88%
TTM Avg
5.78%
3Y Avg
3.95%
5Y Avg
3.33%
Market Cap
$2.51B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
Free Cash Flow Yield
3.06%
TTM Avg
2.66%
3Y Avg
2.65%
5Y Avg
2.78%
Market Cap
$2.87B
Free Cash Flow Yield
1.79%
TTM Avg
2.05%
3Y Avg
1.80%
5Y Avg
1.80%
Market Cap
$2.87B
Free Cash Flow Yield
2.76%
TTM Avg
3.13%
3Y Avg
2.70%
5Y Avg
2.70%
Market Cap
$2.88B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.64B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | N/A | 3.15% | 3.15% | 3.15% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | N/A | 0.77% | 2.82% | 3.32% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 5.88% | 5.78% | 3.95% | 3.33% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | N/A | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 3.06% | 2.66% | 2.65% | 2.78% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 1.79% | 2.05% | 1.80% | 1.80% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 2.76% | 3.13% | 2.70% | 2.70% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 4.97% | 2.84% | 1.97% | 1.97% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
